BiotechTube
Home/AccuGenomics/Tom Morrison, Ph.D.
TM

Tom Morrison, Ph.D.

Chief Scientific Officer

AccuGenomics

Therapeutic Areas

OncologyInfectious Disease

AccuGenomics Pipeline

DrugIndicationPhase
Accukit™ Myeloid DNAAcute Myeloid Leukemia (MRD & Actionable Mutations)Commercial
SNAQ-SEQ for ctDNALiquid Biopsy / Solid TumorsCommercial
SNAQ-SEQ for BiocontaminantsAdventitious Agent Detection in BiomanufacturingCommercial
SNAQ-SEQ for CNVsCopy Number Variation DetectionCommercial
SNAQ-SEQ for SARS-CoV-2COVID-19 Sequencing AssaysCommercial
SNAQ-SEQ for RNA-SeqGene Expression ProfilingDevelopment

Leadership Team at AccuGenomics

NL
Nick Lazaridis, Ph.D.
President
DD
Dan Dilks
SVP Business Development & Commercial
View full AccuGenomics profile